KRAS, APC and TP53 are the most commonly mutated genes reported for human CRC [3, 11]: adenoma progression is associated with loss of APC paired with oncogenic mutations in KRAS; malignant transformation is associated with additional mutations in TP53 [12, 13]. The gene discussed is KRAS; the disease is adenoma.